Gilead Sciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
BERG PAUL director
 Non-qualified stock option 6,500 $4.78 $31,076
Option
BERG PAUL director
 Common Stock 6,500 $4.78 $31,076
Sale
MARTIN JOHN C director
 Common Stock 35,000 $65.34 $2,286,900
Option
MARTIN JOHN C director
 Common Stock 35,000 $2.86 $100,065
Option
MARTIN JOHN C director
 Non-qualified stock option (right to buy) 35,000 $2.86 $100,065
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 3,550 $13.6 $48,291
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 3,550 $64.13 $227,661
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right-to-buy) 3,550 $13.6 $48,291
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 8,000 $7.4 $59,192
Option
MILLIGAN JOHN F director, officer: President an..
 Common Stock 4,060 $7.08 $28,737
Option
MILLIGAN JOHN F director, officer: President an..
 Incentive Stock Option (right to buy) 4,060 $7.08 $28,737
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Incentive Stock Option (right to buy) 4,000 $7.4 $29,596
Option
MARTIN JOHN C director
 Non-qualified stock option (right to buy) 35,000 $2.86 $100,065
Option
MARTIN JOHN C director
 Common Stock 35,000 $2.86 $100,065
Sale
MARTIN JOHN C director
 Common Stock 35,000 $65.45 $2,290,715
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 1,200 $67 $80,400
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 1,200 $67 $80,400
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right to buy) 1,200 $67 $80,400
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 3,550 $13.6 $48,291
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right-to-buy) 3,550 $13.6 $48,291
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 3,550 $64.94 $230,537
Option
LEE WILLIAM A officer: SVP, Research
 Common Stock 20,000 $3.27 $65,320
Option
LEE WILLIAM A officer: SVP, Research
 Incentive Stock Option (right to buy) 20,000 $3.27 $65,320
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right-to-buy) 100 $13.6 $1,360
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 100 $13.6 $1,360
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 100 $13.6 $1,360
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 36,528 $10.3 $376,385
Option
MOORE NICHOLAS G director
 Common Stock 30,000 $26.73 $801,900
Sale
MOORE NICHOLAS G director
 Common Stock 29,920 $68.54 $2,050,747
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Incentive Stock Option (right to buy) 4,000 $9.34 $37,376
Sale
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 36,328 $63.68 $2,313,185
Sale
MOORE NICHOLAS G director
 Common Stock 100 $68.3 $6,830
Option
MOORE NICHOLAS G director
 Non-qualified stock option (right to buy) 30,000 $26.73 $801,900
Option
MARTIN JOHN C director
 Common Stock 35,000 $2.86 $100,065
Option
MARTIN JOHN C director
 Non-qualified stock option (right to buy) 35,000 $2.86 $100,065
Sale
MARTIN JOHN C director
 Common Stock 35,000 $66.66 $2,333,240
Sale
DENNY JAMES M director
 Common Stock 30,000 $5.13 $153,990
Option
DENNY JAMES M director
 Non-qualified Stock Option (right to buy) 40,000 $5.13 $205,320
Option
BERG PAUL director
 Non-Qualified Stock Option 6,500 $4.78 $31,076
Option
BERG PAUL director
 Common Stock 6,500 $4.78 $31,076
Option
DENNY JAMES M director
 Common Stock 40,000 $5.13 $205,320
Sale
BERG PAUL director
 Common Stock 6,500 $69.42 $451,211
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right to buy) 4,750 $13.6 $64,614
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $68.6 $325,864
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $13.6 $64,614
Option
MILLIGAN JOHN F director, officer: President an..
 Common Stock 30,000 $7.4 $221,970
Option
MILLIGAN JOHN F director, officer: President an..
 Non-Qualified Stock Option (right to buy) 30,000 $7.4 $221,970
Sale
MILLIGAN JOHN F director, officer: President an..
 Common Stock 30,000 $68.68 $2,060,490
Option
DAVIGNON ETIENNE director
 Non-Qualified Stock Option (right to buy) 40,000 $3.13 $125,000
Option
DAVIGNON ETIENNE director
 Common Stock 40,000 $3.13 $125,000

Showing 2600 to 2650 of 3053 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: